Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11903953 Remdesivir treatment methods

Patent 11903953 was granted and assigned to Gilead Sciences on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 22 Feb, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 22 Feb, 2024
Edits made to:
Infobox (+94 properties)
Article (+312 characters)
‌

 US Patent 11903953 Remdesivir treatment methods

Article

Patent abstract

Provided herein are methods of treating or preventing a viral infection in a subject comprising administering a compound of Formula I, Formula Ia, or Formula Ib, or a pharmaceutically acceptable salt thereof, wherein the subject is not being treated with chloroquine, or an analog or salt thereof.

Infobox
Is a
Patent
Patent
0
Patent Applicant
Gilead Sciences
Gilead Sciences
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119039530
Patent Inventor Names
Tomas Cihlar0
Date of Patent
February 20, 2024
0
Patent Application Number
181288500
Date Filed
March 30, 2023
0
Patent Citations
‌
US Patent 7105493 Methods and compositions for treating flaviviruses and pestiviruses
0
‌
US Patent 7125855 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
0
‌
US Patent 7166604 Antiviral agents
0
‌
US Patent 7176203 Imidazo-triazine derivatives as ligands for gaba receptors
0
‌
US Patent 7268119 Tricyclic nucleosides or nucleotides as therapeutic agents
0
‌
US Patent 7285658 Nucleotide mimics and their prodrugs
0
‌
US Patent 7368437 Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents
0
‌
US Patent 7390791 Prodrugs of phosphonate nucleotide analogues
0
‌
US Patent 7429571 Therapeutic furopyrimidines and thienopyrimidines
0
‌
US Patent 7514410 Hepatitis C therapies
0
‌
US Patent 7560434 AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
0
‌
US Patent 7598230 Nucleotide mimics and their prodrugs
0
‌
US Patent 7608597 Methods and compositions for treating hepatitis C virus
0
‌
US Patent 7713941 Tricyclic nucleosides or nucleotides as therapeutic agents
0
‌
US Patent 7803788 Prodrugs of phosphonate nucoleotide analogues
0
‌
US Patent 7807653 Nucleotide mimics and their prodrugs
0
‌
US Patent 7842672 Phosphonate inhibitors of HCV
0
‌
US Patent 7951787 Phosphoramidate compounds and methods of use
0
‌
US Patent 7973013 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 7994139 Antiviral therapeutic agents
0
‌
US Patent 8008264 1′-substituted carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 8012941 Carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 8012942 Carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 8071568 Nucleoside aryl phosphoramidates for the treatment of RNA-dependent RNA viral infection
0
‌
US Patent 8119607 Bicyclic nucleosides and nucleotides as therapeutic agents
0
‌
US Patent 8242085 Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
0
‌
US Patent 8318682 1′substituted carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 8415308 1′-substituted-carba-nucleoside prodrugs for antiviral treatment
0
‌
US Patent 8455451 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 8853171 1′-substituted carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 8871737 Substituted nucleotide analogs
0
‌
US Patent 8889159 Compositions and methods for treating hepatitis C virus
0
‌
US Patent 8980865 Substituted nucleotide analogs
0
‌
US Patent 9090642 Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
0
‌
US Patent 9243022 Substituted nucleosides, nucleotides and analogs thereof
0
‌
US Patent 9249174 Substituted nucleosides, nucleotides and analogs thereof
0
‌
US Patent 9278990 Substituted nucleotide analogs
0
‌
US Patent 9388208 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
0
‌
US Patent 9393256 Methods for treating HCV
0
‌
US Patent 9452154 Methods for treating HCV
0
‌
US Patent 9481703 HCV polymerase inhibitors
0
‌
US Patent 9487544 Methods for the preparation of diasteromerically pure phosphoramidate prodrugs
0
‌
US Patent 9504701 Methods for treating viral infections using hydrogen sulfide donors
0
‌
US Patent 9540411 HCV polymerase inhibitors
0
‌
US Patent 9549941 Compositions and methods for treating hepatitis C virus
0
‌
US Patent 9605018 Substituted nucleotide analogs
0
‌
US Patent 9616076 Methods for treating viral infections using hydrogen sulfide donors
0
‌
US Patent 9701682 Pyrrolo[1,2-
0
‌
US Patent 9724360 Methods for treating
0
‌
US Patent 9828408 HCV polymerase inhibitors
0
‌
US Patent RE46762 1′-substituted carba-nucleoside analogs for antiviral treatment
0
‌
US Patent 9949994 Methods for treating
0
‌
US Patent 10023600 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
0
‌
US Patent 10034893 5, 6-D
0
‌
US Patent 10059716 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
0
‌
US Patent 11225508 Mouse-adapted SARS-CoV-2 viruses and methods of use thereof
0
‌
US Patent 10065958 Methods and compounds for treating Paramyxoviridae virus infections
0
‌
US Patent 10251898 Methods for treating Filoviridae virus infections
0
‌
US Patent 10251904 Methods for treating arenaviridae and coronaviridae virus infections
0
‌
US Patent 10377761 Pyrrolo[1,2-f][1,2,4]triazines useful for treating respiratory syncitial virus infections
0
‌
US Patent RE47589 Phosphoramidate compounds and methods of use
0
‌
US Patent 10675296 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
0
‌
US Patent 10682368 Methods of treating feline coronavirus infections
0
‌
US Patent 10695357 Methods for treating filoviridae virus infections
0
‌
US Patent 10695361 Methods for treating arenaviridae and coronaviridae virus infections
0
‌
US Patent 10696679 Methods and compounds for treating paramyxoviridae virus infections
0
‌
US Patent 10836787 Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate
0
‌
US Patent 10988498 Processes and intermediates for the preparation of 1′-substituted carba-nucleoside analogs
0
‌
US Patent 11007208 Methods for treating arenaviridae and coronaviridae virus infections
0
‌
US Patent 11260070 Methods of treating feline coronavirus infections
0
‌
US Patent 11266666 Methods for treating
0
‌
US Patent 11266681 Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections
0
‌
US Patent 11344565 Methods for the preparation of ribosides
0
‌
US Patent 11377456 Crystalline form of Remdesivir
0
‌
US Patent 11382926 Methods for treating
0
‌
US Patent 11492353 Methods and compounds for treating
0
‌
US Patent 11541071 Nucleoside derivatives and methods of use thereof
0
‌
US Patent 11597742 Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate
0
‌
US Patent 11660307 Methods for treating SARS CoV-2 infections
0
‌
US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
0
‌
US Patent 6909011 Process for preparing protected, enantiomer-enriched cyanohydrins by in-situ derivatization
0
‌
US Patent 7078403 Antiviral agents
0
Patent Primary Examiner
‌
Kamal A Saeed
0
CPC Code
‌
A61P 31/14
0
‌
A61K 31/675
0

Find more entities like US Patent 11903953 Remdesivir treatment methods

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.